We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$55.2M
(+29%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
43.97%
Holding
439
New
112
Increased
115
Reduced
72
Closed
39
Avg Time Held
1.3
quarters
Top 10 Avg Time Held
1.4
quarters
Top 20 Avg Time Held
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$24.2M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.84M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$2.46M |
| 4 |
ExxonMobil
XOM
|
+$2.14M |
| 5 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.22M |
| 2 |
Microsoft
MSFT
|
+$2.06M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.93M |
| 4 |
Blackrock
BLK
|
+$1.33M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.95% |
| 2 | Technology | 9.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Industrials | 5.97% |
| 5 | Consumer Staples | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Lowe's Companies
LOW
$104B
| $1.99M | 0.82% |
14,736
+1,601
| +12% | +$183K |
2019 Q4
2 quarters
|
|
27
Walmart Inc
WMT
$905B
| $1.96M | 0.81% |
49,134
+3,582
| +8% | +$147K |
2019 Q4
2 quarters
|
|
|
28
Bristol-Myers Squibb
BMY
$118B
| $1.9M | 0.78% |
920
-32,218
| -97% | -$1.93M |
2019 Q4
2 quarters
|
|
29
iShares MSCI USA Momentum Factor ETF
MTUM
$19.5B
| $1.89M | 0.78% |
14,440
+3,176
| +28% | +$384K |
2019 Q4
2 quarters
|
|
30
Honeywell
HON
$66.3B
| $1.88M | 0.78% |
13,809
+4,026
| +41% | +$533K |
2019 Q4
2 quarters
|
|
31
Procter & Gamble
PG
$359B
| $1.88M | 0.78% |
15,742
-253
| -2% | -$29.5K |
2019 Q4
2 quarters
|
|
32
Analog Devices
ADI
$198B
| $1.86M | 0.76% |
15,131
+1,662
| +12% | +$183K |
2019 Q4
2 quarters
|
|
33
Walt Disney
DIS
$187B
| $1.78M | 0.74% |
16,015
+1,909
| +14% | +$211K |
2019 Q4
2 quarters
|
|
34
Nike
NKE
$51.6B
| $1.76M | 0.73% |
17,996
+1,908
| +12% | +$176K |
2019 Q4
2 quarters
|
|
35
Johnson & Johnson
JNJ
$607B
| $1.76M | 0.72% |
12,502
-94
| -0.7% | -$13.7K |
2019 Q4
2 quarters
|
|
36
Dominion Energy
D
$54.4B
| $1.75M | 0.72% |
23,610
+93
| +0.4% | +$7.46K |
2019 Q4
2 quarters
|
|
37
General Mills
GIS
$17.1B
| $1.67M | 0.69% |
27,139
+1,660
| +7% | +$100K |
2019 Q4
2 quarters
|
|
38
PepsiCo
PEP
$174B
| $1.65M | 0.68% |
12,514
+3
| +0% | +$395 |
2019 Q4
2 quarters
|
|
39
Comcast
CMCSA
$73.7B
| $1.65M | 0.68% |
42,324
+5,099
| +14% | +$194K |
2019 Q4
2 quarters
|
|
40
Starbucks
SBUX
$105B
| $1.63M | 0.67% |
22,180
+2,532
| +13% | +$190K |
2019 Q4
2 quarters
|
|
41
Boeing
BA
$147B
| $1.6M | 0.66% |
8,711
+8,144
| +1,436% | +$1.25M |
2019 Q4
2 quarters
|
|
42
Coca-Cola
KO
$391B
| $1.47M | 0.61% |
32,951
-49
| -0.1% | -$2.26K |
2019 Q4
2 quarters
|
|
43
Altria Group
MO
$121B
| $1.45M | 0.6% |
32,432
+1,086
| +3% | +$42.4K |
2019 Q4
2 quarters
|
|
|
44
Microsoft
MSFT
$3.99T
| $1.45M | 0.6% |
7,103
-11,358
| -62% | -$2.06M |
2019 Q4
2 quarters
|
|
45
Pfizer
PFE
$166B
| $1.43M | 0.59% |
46,166
+97
| +0.2% | +$3.29K |
2019 Q4
2 quarters
|
|
46
General Dynamics
GD
$90.6B
| $1.41M | 0.58% |
9,414
+1,243
| +15% | +$176K |
2019 Q4
2 quarters
|
|
47
T. Rowe Price
TROW
$21.2B
| $1.4M | 0.58% |
11,357
+221
| +2% | +$25.2K |
2019 Q4
2 quarters
|
|
48
RTX Corp
RTX
$250B
| $1.37M | 0.57% |
22,309
+5,056
| +29% | +$316K |
2019 Q4
2 quarters
|
|
49
AT&T
T
$157B
| $1.36M | 0.56% |
67,157
-4,512
| -6% | -$103K |
2019 Q4
2 quarters
|
|
50
Southern Company
SO
$101B
| $1.31M | 0.54% |
25,352
-328
| -1% | -$18.2K |
2019 Q4
2 quarters
|
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q2 2020 Portfolio in Review
As of Q2 2020, Leelyn Smith held 439 positions worth $243M, up 29% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Leelyn Smith deployed $46.5M of net new capital in Q2 2020, opening 112 new positions and adding to 115 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Clorox, an estimated $2.22M trimmed.
- Leelyn Smith's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
- Leelyn Smith added most to 3M in Q2 2020, an estimated $24.2M increase.
- Leelyn Smith's biggest Q2 2020 reduction was Clorox, cutting an estimated $2.22M.
- Leelyn Smith fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $333K.
- Leelyn Smith's ten largest holdings make up 44% of its $243M portfolio in Q2 2020.
- Leelyn Smith opened 112 new positions and closed 39 in Q2 2020.
- Leelyn Smith's portfolio value rose 29% quarter-over-quarter to $243M.
Based on Leelyn Smith's 13F filing for Q2 2020, filed 6 Aug 2020.